中医杂志(英文版)2024,Vol.44Issue(5) :871-884.DOI:10.19852/j.cnki.jtcm.20240806.007

Traditional Chinese Medicine in the treatment of recurrent respiratory tract infections in children:an overview of systematic reviews and Meta-analyses

DENG Yasheng HAN Siyin XI Lanhua HUANG Hui LIANG Tianwei ZHENG Yiqing FAN Yanping LIN Jiang
中医杂志(英文版)2024,Vol.44Issue(5) :871-884.DOI:10.19852/j.cnki.jtcm.20240806.007

Traditional Chinese Medicine in the treatment of recurrent respiratory tract infections in children:an overview of systematic reviews and Meta-analyses

DENG Yasheng 1HAN Siyin 2XI Lanhua 3HUANG Hui 1LIANG Tianwei 1ZHENG Yiqing 1FAN Yanping 1LIN Jiang2
扫码查看

作者信息

  • 1. School of Basic Medical Sciences,Guangxi University of Chinese Medicine,Nanning 530200,China
  • 2. School of Basic Medical Sciences,Guangxi University of Chinese Medicine,Guangxi Key Laboratory of Marine Drugs,Nanning 530200,China
  • 3. Department of Pharmacy,Hainan Traditional Chinese Medicine Hospital,Haikou 570203,China
  • 折叠

Abstract

OBJECTIVE:To evaluate and summarise the evidence from published Meta-analyses/systematic reviews(MAs/SRs)of Traditional Chinese Medicine(TCM)in the treatment of recurrent respiratory tract infections(RRTIs)and to provide a scientific basis for the clinical treatment of RRTIs with TCM.METHODS:Studies were retrieved from Chinese and English databases including the China National Knowledge Infrastructure,Wanfang database,China Science and Technology Journal Database,SinoMed,PubMed,Web of Science,the Cochrane Library and EMbase from their establishment date to March 2023.Involved studies were screened,extracted,and evaluated for quality by two researchers independently.The a measurement tool to assess systematic reviews(AMSTAR)2 scale was used for methodological quality evaluation,as well as the preferred reporting items for systematic reviews and Meta-analyses(PRISMA)2020 statement for report quality evaluation,the risk of bias in systematic reviews(ROBIS)tool for risk of bias,and the grading of recommendations,assessment,development and evaluation(GRADE)quality assessment tool for evidence quality.RESULTS:Twenty MAs/SRs studies were included,including analyses of 274 original studies involving 38335 patients with RRTIs.The AMSTAR 2 scale evaluation results showed that 19 studies were of very low quality and one of moderate quality.The ROBIS evaluation results showed that 11 MAs/SRs were at high risk and nine at low risk of bias.The PRISMA 2020 report quality showed the included studies had scores between 23.5 and 35.5,among them one with high quality,17 with moderate quality and two with low quality.The GRADE system results showed that among 126 outcome indicators,only 17 had moderate quality of evidence,27 had low quality,82 had very low quality,and none had high quality.CONCLUSIONS:The MAs/SRs methodological quality of using TCM for treatment RRTIs is generally poor,the quality of reports as well as of evidence is generally low,and the risk of bias is high;therefore we should treat these results with caution.

Key words

respiratory tract infections/child/medicine,Chinese traditional/Meta-analysis/systematic review/randomized controlled trial

引用本文复制引用

出版年

2024
中医杂志(英文版)
中国中医药学会 中国中医研究院

中医杂志(英文版)

影响因子:0.855
ISSN:0255-2922
段落导航相关论文